The FDA approved lumateperone (Caplyta) as an adjunctive therapy with antidepressants for the treatment of major depressive ...
Prior to the march, the protesters, many of them former federal public health employees, convened near a stage and listened ...
The FDA announced six more awardees for the FDA Commissioner's National Priority Voucher (CNPV) pilot program designed to ...
The ruling by U.S. District Judge John J. McConnell Jr. gave President Donald Trump's administration until Friday to make the ...
The Big Beautiful Bill arrives at a time when wages are already increasingly unequal across industries. Amongst top publicly ...
An economic evaluation found that screening followed by intensive lifestyle intervention plus either semaglutide (Ozempic, ...
The American Academy of Pediatrics (AAP) and other medical groups have updated their lawsuit against HHS Secretary Robert F.
HOUSTON -- A novel self-administered shot that inhibits two key immunoregulatory cytokines reduced proteinuria in patients ...
Medicare will cover semaglutide (Wegovy) and tirzepatide (Zepbound) for their weight management indications for people with ...
Patients with plateaued weight loss or who reached their weight-related goals on a GLP-1 receptor agonist were able to ...
A federal judge has dismissed a lawsuit challenging the deportation of a doctor from Lebanon who was deported from Boston's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results